ROK
46
3
GWW
50
9
ROP
44
6
ZION
49
9
XOM
33
3
AIG
38
5
EOG
28
2
SNA
56
3
MKC
54
3
MS
64
3
AIZ
61
5
BXP
39
5
CRM
65
6
PRU
39
3
DTE
49
16
USB
50
3
CAT
47
3
GS
65
16
WFC
58
8
AFL
34
6
ROK
46
3
GWW
50
9
ROP
44
6
ZION
49
9
XOM
33
3
AIG
38
5
EOG
28
2
SNA
56
3
MKC
54
3
MS
64
3
AIZ
61
5
BXP
39
5
CRM
65
6
PRU
39
3
DTE
49
16
USB
50
3
CAT
47
3
GS
65
16
WFC
58
8
AFL
34
6
Financhill
Back

Molecular Partners AG Vs. NLS Pharmaceutics Industry Stock Comparison

Sell
28

MOLN
Molecular Partners AG

Last Price:
$5.18
Seasonality Move:
-1.41%
Sell
28

NLSP
NLS Pharmaceutics

Last Price:
$1.91
Seasonality Move:
0.34%
Sell
28
Molecular Partners AG (MOLN) is a Sell

Is Molecular Partners AG a Buy, Sell or Hold?

  • The current Molecular Partners AG [MOLN] share price is $5.08. The Score for MOLN is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • MOLN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
NLS Pharmaceutics (NLSP) is a Sell

Is NLS Pharmaceutics a Buy, Sell or Hold?

  • The current NLS Pharmaceutics [NLSP] share price is $1.92. The Score for NLSP is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • NLSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MOLN Stock Price Chart

What is Molecular Partners AG's stock price today?

  • The Molecular Partners AG share price today is $5.08
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MOLN is experiencing selling pressure, which indicates risk of future bearish movement.

NLSP Stock Price Chart

What is NLS Pharmaceutics's stock price today?

  • The NLS Pharmaceutics share price today is $1.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing slight selling pressure.

MOLN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 39.61 Sell
Chaikin Money Flow: -10379 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.29 - 5.73) Sell
Bollinger Bands (100): (5.01 - 6.29) Sell

NLSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.46 Sell
Relative Strength Index (14 RSI): 33.75 Sell
Chaikin Money Flow: -115060 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.01 - 3.29) Sell
Bollinger Bands (100): (3.09 - 6.53) Sell

MOLN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.34 Sell
20-day SMA: 5.52 Sell
50-day SMA: 5.63 Sell
200-day SMA: 5.3 Sell
8-day EMA: 5.31 Sell
20-day EMA: 5.46 Sell
50-day EMA: 5.54 Sell
200-day EMA: 5.45 Sell

NLSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.99 Sell
20-day SMA: 2.5 Sell
50-day SMA: 3.46 Sell
200-day SMA: 5.95 Sell
8-day EMA: 2.07 Sell
20-day EMA: 2.44 Sell
50-day EMA: 3.34 Sell
200-day EMA: 8.07 Sell

Molecular Partners AG Earnings Growth & MOLN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and a decrease next year of $0.04 per share.

NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Molecular Partners AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NLS Pharmaceutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):